Prof. Leslie Leiserowitz first became intrigued by malaria when he was a young boy in South Africa. His father, who scouted the continent in search of wood for the family business, brought back not only tales of elephants and gorillas but also skin rashes and ringing in his ears, side effects of the quinine he took to prevent malaria.
Category: business – Page 36
Fin+AI 2024 Interview | Chris Fronda, Co-Founder and Chief Logic Officer, Logictry on AI & Education
In this interview I speak with Chris Fronda, CEO of Logictry.
In this interview Bruce Burke speaks with Chris Fronda, CEO of Logictry. Scaling the world’s wisdom to help everyone make better decisions faster. Chris is presenting at Fin+AI 2024 Conference, October 2–4, 2024 at Le Meridien in Dania Beach, Florida. Meet Chris and other leaders at Fin+AI.
https://www.finaiconference.com/chris…
Chris Fronda is a former Enterprise Product Manager, 4X startup founder, and 15+ year full stack software architect with experience building web apps, native mobile apps, blockchain dapps, scalable cloud architectures, expert systems, and custom large language models.
Chris is a proven expert in technology and innovation having worked with clients ranging from small businesses to Fortune 10 companies and helps organizations systematize and scale their business leveraging the latest technological advancements.
Mike Kelly — President & CEO, NervGen Pharma — Innovative Treatments To Enable Nervous System Repair
Mike Kelly is President & Chief Executive Officer of NervGen Pharma Corp. (https://nervgen.com/), a clinical-stage biotech company dedicated to developing innovative treatments to enable nervous system repair in the settings of traumatic injury and disease.
NervGen’s lead drug candidate, NVG-291, is being evaluated in a Phase 1b/2a clinical trial in an initial target indication, spinal cord injury. NervGen has initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury.
Mr. Kelly brings three decades of pharmaceutical experience playing instrumental roles in the creation, development and strengthening of several companies.
Most recently, Mr. Kelly served as President of US Operations for Adapt Pharma, Inc. from March 2016 to June 2019, and played a key leadership role in the development and commercialization of NARCAN (naloxone HCl) Nasal Spray in the US and Canada and in the eventual sale to Emergent BioSolutions for US$735 million.
Prior to his tenure at Adapt Pharma, Inc., Mr. Kelly served as the Chief Executive Officer and a Director of Covis Pharmaceuticals, Inc., where, along with its European affiliate, grew and sold the company assets for US$1.2 billion. Mr. Kelly was also a member of the founding management team of Azur Pharma Limited, a specialty pharmaceutical company, and later, following a strategic merger, served as the Senior Vice President of Sales and Marketing for Jazz Pharmaceuticals Inc. Mr. Kelly has also held various commercial and medical roles at Guilford Pharmaceuticals Inc., ViroPharma Incorporated and TAP Pharmaceuticals Inc. and has been a Director of ARS Pharmaceuticals Inc. since May 2019.
Mr. Kelly holds a Bachelor of Science in business administration from The College of New Jersey and a Master of Business Administration from Rider University.
Charoen Thani Hotel, Khon Kaen. · 260 Sri Chant Rd, Nai Mueang, Mueang Khon Kaen District, Khon Kaen 40000, Thailand
The name of the conference will be lifeboat foundation conference for polymaths futuristics and visionaries.
The place will be this hotel.
https://maps.app.goo.gl/sdG14SRcrJEJGYGH6
With nice accommodation equipped with fitness swimming pool sauna Jacuzzi and restaurant.
Please help me organise it…
Dear All Polymaths I will arrange the conference for polymaths like all of you.
Slack researcher discusses the fear, loathing and excitement surrounding AI in the workplace
People with AI are going to replace people without AI.
SAN FRANCISCO (AP) — Artificial intelligence’s recent rise to the forefront of business has left most office workers wondering how often they should use the technology and whether a computer will eventually replace them.
Those were among the highlights of a recent study conducted by the workplace communications platform Slack. After conducting in-depth interviews with 5,000 desktop workers, Slack concluded there are five types of AI personalities in the workplace: “The Maximalist” who regularly uses AI on their jobs; “The Underground” who covertly uses AI; “The Rebel,” who abhors AI; “The Superfan” who is excited about AI but still hasn’t used it; and “The Observer” who is taking a wait-and-see approach.
Microsoft introduces autonomous AI agents
Microsoft on Monday said it was enhancing its AI offerings with new autonomous agent capabilities as the tech titan aims to accelerate business adoption of artificial intelligence.
AI agents are specialized programs designed to perform routine tasks autonomously, such as sifting through sales leads or handling customer service inquiries.
The AI agent has become the newest buzzword for major software companies that are investing billions in powerful AI models, which they believe will shape the future of computing.
AI Explained: AI Agents Are Quietly Taking Over Everyday Tasks
Although UBTech is leaving 10% of work for humans in management, other AI tech is being specifically developed for that niche: OpenAI’s new framework, Swarm, allows AI agents to collaborate and independently execute complex tasks, potentially boosting business efficiency.
Artificial intelligence agents are everywhere, quietly reshaping industries and automating tasks we didn’t think possible a few years ago. Unlike basic automation, these AI agents can handle complex jobs, think independently and learn from their environment. The result? Healthcare, finance and logistics businesses are seeing rapid gains in efficiency — and, in some cases, doing away with manual work altogether.
What are AI agents exactly? They’re software programs that carry out specific tasks without constant supervision. Whether handling customer requests, diagnosing medical conditions or predicting market trends, AI agents are versatile workhorses. Instead of waiting for humans to input every command, these agents operate autonomously, reacting to real-time data and adjusting their actions accordingly.
Microsoft recently unveiled new AI tools allowing healthcare organizations to build customized AI agents for appointment scheduling, clinical trial matching, and patient triage. These agents are designed to streamline workflows and improve efficiency, helping healthcare providers manage workloads and enhance patient care.
